Transcriptional studies show that loss of Sdc-1 (13, 16) and enhanced expression of HPSE (17–19) correlate with tumor growth, invasion, metastatic potential, and reduced postoperative survival of cancer patients (20). The gene discussed is SDC1; the disease is neoplasm.